Young-Suk Jung | Biotechnology | Best Researcher Award

Published on by Computer Scientists Awards

Best Researcher Award

Young-Suk Jung
Pusan National University College of Pharmacy

Young-Suk Jung
Affiliation Pusan National University College of Pharmacy
Country South Korea
Scopus ID 56428348300
Documents 196
Citations 5103
h-index 39
Subject Area Biotechnology
Event Computer Scientists Awards
ORCID 0000-0003-0299-4451

Young-Suk Jung is a researcher affiliated with the Pusan National University College of Pharmacy, South Korea. His scholarly work has contributed to biotechnology, pharmaceutical sciences, molecular biology, toxicology, and translational biomedical research. Through a substantial publication record, extensive citation impact, and sustained academic productivity, Jung has established a recognized presence within the international scientific community. His research activities encompass experimental and applied biotechnology, emphasizing cellular mechanisms, disease biology, pharmacological interventions, and innovative therapeutic approaches.[1]

Abstract

This article presents an academic overview of Young-Suk Jung and evaluates his scholarly profile in relation to recognition through the Best Researcher Award. The assessment considers research productivity, publication output, citation influence, interdisciplinary engagement, and scientific contributions within biotechnology and pharmaceutical sciences. Available bibliometric indicators demonstrate substantial research visibility and sustained academic influence, supporting consideration for international research distinction.[1]

Keywords

Biotechnology, Pharmaceutical Sciences, Drug Discovery, Molecular Biology, Toxicology, Biomedical Research, Translational Medicine, Research Excellence, Scientific Impact, Citation Analysis, Academic Recognition, Therapeutic Innovation.

Introduction

Contemporary biotechnology increasingly relies on interdisciplinary research integrating molecular biology, pharmacology, toxicology, and clinical translation. Researchers capable of bridging fundamental biological discoveries with practical therapeutic applications contribute significantly to scientific advancement. Young-Suk Jung’s academic portfolio reflects engagement across these domains through extensive peer-reviewed scholarship and collaborative research initiatives.[1]

The evaluation of academic excellence frequently incorporates publication productivity, citation performance, innovation, and contributions to knowledge generation. Within these criteria, Jung’s research profile demonstrates characteristics associated with internationally recognized scientific achievement.[2]

Research Profile

  • 196 indexed scholarly documents.
  • More than 5,100 citations across scientific literature.
  • h-index of 39 indicating consistent scholarly influence.
  • Participation in multidisciplinary biomedical investigations.

The research profile reflects both productivity and impact. Bibliometric indicators suggest that Jung’s publications have received sustained attention from researchers working in biotechnology, pharmacology, toxicology, and related biomedical disciplines.[1]

Research Contributions

Young-Suk Jung has contributed to advancing scientific understanding of disease mechanisms, therapeutic targets, pharmacological responses, and cellular signaling pathways. His work frequently addresses biological processes relevant to human health and disease management.[2]

Publications

Young-Suk Jung has authored and co-authored numerous peer-reviewed publications in biotechnology, pharmaceutical sciences, and biomedical research. The breadth of publication activity demonstrates continuous scholarly engagement and international research collaboration.[1]

Research Impact

Research impact is commonly assessed through citation metrics, publication influence, and knowledge dissemination. With 5,103 citations and an h-index of 39, Young-Suk Jung demonstrates measurable scholarly impact across multiple scientific communities.[1]

The citation performance indicates that his research findings have informed subsequent investigations and contributed to the broader scientific discourse. Such influence is often regarded as an indicator of research quality, relevance, and sustainability within a field.[2]

Award Suitability

Evaluation for the Best Researcher Award generally considers originality, productivity, impact, and contributions to scientific advancement. Based on available bibliometric information, Young-Suk Jung exhibits several attributes commonly associated with award recognition, including sustained publication activity, significant citation influence, interdisciplinary research engagement, and measurable scholarly visibility.[1]

Conclusion

Young-Suk Jung represents an established researcher whose academic profile reflects sustained productivity, measurable scientific influence, and active contributions to biotechnology and pharmaceutical sciences. Available indicators support recognition of his research achievements and demonstrate characteristics consistent with consideration for the Best Researcher Award within an international academic context.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Young-Suk Jung, Author ID 56428348300. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=56428348300
  2. ORCID. (n.d.). Young-Suk Jung researcher profile and scholarly activities.
    https://orcid.org/0000-0003-0299-4451
  3. Jung, Y.-S. et al. (2014). Biomedical and pharmacological research publication.
    DOI: https://doi.org/10.1016/j.bcp.2014.09.008
  4. Computer Scientists Awards. (n.d.). Best Researcher Award information.
    https://computerscientists.net/

Dr. Tun Naw Sut | Biotechnology | Best Researcher Award

Published on by Computer Scientists Awards

Dr. Tun Naw Sut | Biotechnology | Best Researcher Award

Sungkyunkwan University | South Korea

Dr. Sut Tun Naw is a nanomedicine and biomaterials researcher whose work focuses on lipid‐based membrane systems, bio-interfaces, and diagnostic technologies. His scholarly impact is evidenced by strong citation metrics across major databases, including Scopus with more than 787 citations, over 51 indexed documents, and an h-index reflecting sustained contributions to the field. His Google Scholar profile further demonstrates consistent influence with citations approaching 963, an h-index in the high 10, and an extensive record of high-quality publications. Collectively, his research profile highlights significant advancements in supported lipid bilayers, membrane interactions, and nanoscale bioengineering.

Publication Profile

Scopus 

ORCID

Google Scholar

Education Background

Dr. Sut Tun Naw completed a dual doctoral program jointly conferred by Nanyang Technological University in Singapore and Sungkyunkwan University in South Korea, where he conducted interdisciplinary work spanning nanomedicine and chemical engineering. Prior to his doctoral training, he earned a Bachelor of Engineering in Materials Science and Engineering at Nanyang Technological University, where he developed foundational knowledge in biomaterials and surface engineering. His academic journey began with a diploma in biomedical engineering from Ngee Ann Polytechnic, providing him early exposure to medical technologies, diagnostics, and laboratory instrumentation. This integrated academic background enables his cross-disciplinary expertise in nanoscience and biomedical engineering.

Professional Experience

Dr. Sut Tun Naw has developed strong research and engineering competencies through a combination of academic and industry roles. He is currently a postdoctoral fellow at Sungkyunkwan University, where he advances biomimetic lipid membrane systems for biosensing and diagnostic platforms. His earlier experiences at Nanyang Technological University included work as a project officer investigating phospholipid self-assembly and membrane fabrication strategies. He has further contributed to translational research as a research intern at the Institute of Bioengineering and Nanotechnology and held engineering positions in Singapore’s medical technology and manufacturing sectors, where he supported equipment testing, compliance evaluation, and device maintenance.

Awards and Honors

Dr. Sut Tun Naw has been recognized through several competitive distinctions reflecting scientific merit and editorial leadership. His research received support from a national-level Creative Challenge Research Grant awarded by the National Research Foundation of Korea, enabling further development of innovative biomimetic technologies. He contributes to the scholarly community as a guest editor for a special issue on biomimicry and functional materials and serves as a topic editor in the field of membrane science. His academic accomplishments have also been acknowledged by graduate scholarship programs that support outstanding researchers developing advanced chemical and nanotechnology solutions.

Research Focus

Dr. Sut Tun Naw’s research centers on supported lipid bilayers, biomimetic membrane coatings, and nanoscale interactions at solid–liquid interfaces. He investigates how lipid assemblies form, reorganize, and respond to environmental and chemical cues, contributing key insights relevant to biosensors, antiviral strategies, and membrane-based diagnostics. His work also examines protein adsorption, membrane morphology, and the physicochemical behavior of bicelles and fatty-acid systems. Through experimental biophysics, nanofabrication, and surface engineering approaches, he aims to design functional lipid platforms for biomedical detection, molecular analysis, and therapeutic applications. His contributions continue to advance nanomedicine and membrane science.

Top Publications

Sut, T. N., Park, S., Choe, Y., & Cho, N. J. (2019). Characterizing the supported lipid membrane formation from cholesterol-rich bicelles. Langmuir, 35(47), 15063–15070. Cited by approximately thirty-eight articles.

Ferhan, A. R., Yoon, B. K., Park, J. H., Sut, T. N., Chin, H., Jackman, J. A., et al. (2019). Solvent-assisted preparation of supported lipid bilayers. Nature Protocols, 14(7), 2091–2118. Cited by approximately one hundred thirty-nine articles.

Park, J. H., Sut, T. N., Jackman, J. A., Ferhan, A. R., Yoon, B. K., & Cho, N. J. (2017). Controlling adsorption and passivation properties of bovine serum albumin on silica surfaces. Physical Chemistry Chemical Physics, 19(13), 8854–8865. Cited by approximately seventy-eight articles.

Yoon, B. K., Jeon, W. Y., Sut, T. N., Cho, N. J., & Jackman, J. A. (2020). Stopping membrane-enveloped viruses with nanotechnology strategies. ACS Nano, 15(1), 125–148. Cited by approximately seventy articles.

Yoon, B. K., Jackman, J. A., Kim, M. C., Sut, T. N., & Cho, N. J. (2017). Correlating membrane morphological responses with micellar aggregation behavior. Langmuir, 33(11), 2750–2759. Cited by approximately sixty-one articles.

Mariana Sánchez | Biotechnology Award | Best Researcher Award

Published on by Computer Scientists Awards

Prof. Dr. Mariana Sánchez | Biotechnology Award | Best Researcher Award

Professor, Metropolitan Autonomous University, Iztapalapa Unit, Mexico

🌟 Mariana Sánchez Ramos is an accomplished biotechnologist and researcher at the Universidad Autónoma Metropolitana Iztapalapa, Mexico. With expertise in plant tissue culture and natural product synthesis, she has significantly contributed to biotechnological innovations. Her research focuses on producing bioactive compounds from medicinal plants, emphasizing their anti-inflammatory, cytotoxic, and antioxidant properties. 🌱🔬

Publication Profile

ORCID

Education

🎓 Mariana holds a Ph.D. in Natural Sciences from the Biotechnology Research Center (CEIB-UAEM), where she studied callus cultures of Ageratina pichinchensis to produce bioactive compounds. She also earned a Master’s degree in Biotechnology (CEIB-UAEM), focusing on characterizing crude lipase from Serratia marcescens, and a Bachelor’s degree in Biochemical Engineering from Instituto Tecnológico de Acapulco, where she conducted a phytochemical study on Lopezia racemosa. 🧪📚

Experience

👩‍🏫 Mariana has served as a Full-time Associate Professor at the Universidad Autónoma Metropolitana Iztapalapa (2022–2024), where she has led research projects on tissue culture and secondary metabolite production. She also worked in R&D at Biokab S.A. de C.V., contributing to the nutraceutical application of arabinoxylans. Her postdoctoral research at UAM Iztapalapa focused on elicited suspension cell cultures of Ageratina pichinchensis. 🌿💡

Research Interests

💡 Mariana’s research revolves around plant tissue culture, secondary metabolite production, and their biopharmaceutical applications. She is particularly interested in studying the anti-inflammatory, antibacterial, cytotoxic, and antioxidant properties of plant-derived compounds, contributing to health and wellness through biotechnology. 🌸🧬

Awards

🏅 Mariana has received recognition for her innovative research in biotechnology, including her contributions to natural product development and plant tissue culture. Her work bridges scientific discovery with practical applications in pharmacology and industrial biotechnology. 🎖️🌍

Publications

Constituents from Ageratina pichinchensis and Their Inhibitory Effect on Nitric Oxide Production
Applied Sciences, 2024. DOI: 10.3390/app14093942.

University Social Responsibility: Bringing Science to Children
International Journal of Human Sciences Research, 2024. DOI: 10.22533/at.ed.5584142416047.

Cytotoxic Activity of Wild Plant and Callus Extracts of Ageratina pichinchensis and 2,3-Dihydrobenzofuran Isolated from a Callus Culture
Pharmaceuticals, 2023. DOI: 10.3390/ph16101400.

In Silico Study Applied to Secondary Metabolites of Ageratina pichinchensis (Asteraceae) for Cancer and Psoriasis
Revista Mexicana de Investigación en Productos Naturales, 2023.

Anti-inflammatory, Antibacterial, and Antioxidant Activity of Leaf and Cell Culture Extracts of Randia aculeata L. and its Chemical Components by GC-MS
South African Journal of Botany, 2022. DOI: 10.1016/j.sajb.2021.08.036.

 

 

Rahul Ingle | Biotechnology | Best Researcher Award

Published on by Computer Scientists Awards

Dr. Rahul Ingle | Biotechnology | Best Researcher Award

Professor, Datta Meghe College of Pharmacy, DMIHER, Wardha, India

Rahul G. Ingle is an accomplished Professor in Pharmaceutical Sciences, renowned for his diverse expertise in drug development, analytical chemistry, and academia. His journey spans from pioneering research in drug analysis at Wockhardt Research Centre to post-doctoral fellowship at Zhejiang University, China, further enhancing his global outlook. Currently, he enriches the academic landscape at Datta Meghe College of Pharmacy, leveraging his extensive research acumen to mentor aspiring pharmacists.

Profile

Google Scholar

Education 🎓

Dr. Ingle’s academic voyage is marked by excellence. He earned his Ph.D. in Pharmaceutical Sciences & Technology from S.R.T.M. University, following distinguished achievements in M. Pharmacy, B. Pharmacy, and D. Pharmacy, nurturing his passion for pharmaceutical chemistry and research.

Experience 💼

With a rich tapestry of professional roles, Dr. Ingle has left an indelible mark in both academia and industry. From his tenure as a Research Scientist at Wockhardt Research Centre to pivotal post-doctoral research in China, he has honed his skills in drug analysis, stability studies, and collaborative research, ensuring compliance with international standards.

Research Interests 🔬

Dr. Ingle’s research portfolio reflects his interdisciplinary approach and commitment to advancing pharmaceutical sciences. He specializes in biopharmaceutical projects, drug stability, and novel drug discovery methodologies, with a particular focus on monoclonal antibodies, nucleic acids, and anticancer agents.

Awards 🏆

Throughout his illustrious career, Dr. Ingle has garnered numerous accolades, including prestigious honors such as MITCON Training Programme, JRF recipient, and Certificate of Merit. His dedication to excellence and scholarly contributions have been recognized both nationally and internationally.

Publications 📖

Application of In Silico Drug Discovery Techniques to Discover a Novel Hit for Target-Specific Inhibition of SARS-CoV-2 Mpro’s Revealed Allosteric binding with MAO-B receptor: A theoretical study to Find a cure for post Covid Neurological disorder – Published in PLOS One, 2023

An Overview of the Stability and Delivery Challenges of Commercial Nucleic Acid Therapeutics – Published in Pharmaceutics, 2023

Current development of bioanalytical sample preparation techniques in pharmaceuticals – Published in Journal of Pharmaceutical Analysis, 2022

Freeze-dried monoclonal antibody formulations are unexpectedly more prone to degradation than liquid formulations under shaking stress – Published in Journal of Pharmaceutical Sciences, 2022

Pre-filled dual-chamber devices (DCDs) – Promising high-quality and convenient drug delivery system – Published in International Journal of Pharmaceutics, 2021